首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >A meta-analysis of probiotic and synbiotic use in elective surgery: Does nutrition modulation of the gut microbiome improve clinical outcome?
【24h】

A meta-analysis of probiotic and synbiotic use in elective surgery: Does nutrition modulation of the gut microbiome improve clinical outcome?

机译:对选择性手术中益生菌和合生元使用的荟萃分析:肠道微生物组的营养调节是否可以改善临床结果?

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Perioperative nutrition modulation of gut microbiota is increasingly used as a strategy for reducing the infective complications of elective surgery. This meta-analysis assessed the effect of probiotic and synbiotic preparations on the incidence of postoperative sepsis. Methods: Randomized controlled trials that compared preoperative dosing of probiotics and synbiotics in patients undergoing elective general surgical procedures were included. The primary outcome measure was the postoperative sepsis rate. Pooled outcome measures were determined using random effects models. Results: Thirteen randomized controlled trials totaling 962 patients were included in this analysis (304 received synbiotics and 182 received probiotics). The incidence of postoperative sepsis was reduced in the probiotic group vs the control (pooled odds ratio [OR] = 0.42; 95% confidence interval [CI], 0.23-0.75; P =.003) and in the synbiotic group vs the control (pooled OR = 0.25; 95% CI, 0.1-0.6; P =.002). However, subgroup analysis failed to identify a significant reduction in the incidence of pneumonia, urinary tract infections, or wound infections in the postoperative phase for either treatment group. Synbiotics reduced the length of postoperative antibiotic use (weighted mean differences = -1.71; 95% CI, -3.2 to -0.21; P =.03). Conclusion: Probiotic and synbiotic nutrition strategies reduce the incidence of postoperative sepsis in the elective general surgery setting. These effects appear more pronounced with the use of synbiotics. High-powered, mechanistic studies are now required for the optimization of pro- and prebiotic regimens to further improve their efficacy.
机译:背景:围手术期肠道微生物群的营养调节越来越多地用作减少择期手术感染并发症的策略。这项荟萃分析评估了益生菌和合生元制剂对术后败血症发生率的影响。方法:纳入随机对照试验,比较接受选择性普外科手术的患者术前使用益生菌和合生元的剂量。主要结局指标为术后败血症发生率。使用随机效应模型确定合并结果量度。结果:这项总共包括962例患者的13项随机对照试验被纳入该分析(304例接受合生素,182例接受益生菌)。益生菌组与对照组相比,术后败血症的发生率降低(合并优势比[OR] = 0.42; 95%置信区间[CI],0.23-0.75; P = .003),而合生素组与对照组相比(合并OR = 0.25; 95%CI,0.1-0.6; P = .002)。但是,亚组分析未能确定任一治疗组术后阶段的肺炎,尿路感染或伤口感染的发生率均显着降低。合生元减少了术后抗生素的使用时间(加权平均差异= -1.71; 95%CI,-3.2至-0.21; P = .03)。结论:益生菌和合生元营养策略可降低选择性普外科手术后败血症的发生率。使用合生素后,这些作用似乎更加明显。为了优化益生元和益生元方案,以进一步提高其功效,现在需要进行强大的机械研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号